Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The role of the TOM complex in stabilizing PINK1 on damaged mitochondria

EF 2022-23

Résumé
Parkinson’s disease (PD) is the second most common neurodegenerative disease leading to severe motor impairment and non-motor symptoms. By 2031, around 163,000 Canadians will be diagnosed with PD, however current treatments do not slow progression of the disease and have bad side effects. We are in dire need of new therapeutic targets. To do so, we must better understand key players causing PD, such as mutations in Parkin and PINK1. In early-onset PD, these enzymes are impaired resulting in the sickness. These proteins are crucial as they remove damaged mitochondria from cells to keep us healthy. The mitochondria is a compartment present in cells, responsible for providing energy. When mitochondria are damaged, Parkin is recruited and clears damage. Parkin is recruited through PINK1, which acts as a damage sensor by accumulating on damaged mitochondria. PINK1 acts like a fire alarm for damage in our body, telling the firemen, Parkin, they are needed. When there is no damage, PINK1 is degraded and removed. For PINK1 to not be degraded, it must bind to a part of the mitochondria called the TOM complex (translocase of the outer membrane complex). This complex is made up of several subunits, but it is unknown how PINK1 interacts with these TOM subunits when mitochondria is damaged. Our objective is to better understand the role of the TOM-complex in the stabilization of PINK1 when there is damage. We will use biochemical approaches that interfere with key connections between PINK1 and TOM subunits. The PINK1-TOM complex is a crucial initiator of a damage repair pathway implicated in PD. This complex could be a potential therapeutic target, reducing suffering of those with PD and the economic burden associated with long-term care of the disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486205
Name
Romanelli Sabrina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of the TOM complex in stabilizing PINK1 on damaged mitochondria
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Damage Sensing; Mitochondria; Parkin; Parkinson'S Disease; Pink1; Pink1-Tom Complex; Tom-Complex; Tom20; Tom7; Ubiquitination
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease leading to severe motor impairment and non-motor symptoms. By 2031, around 163,000 Canadians will be diagnosed with PD, however current treatments do not slow progression of the disease and have bad side effects. We are in dire need of new therapeutic targets. To do so, we must better understand key players causing PD, such as mutations in Parkin and PINK1. In early-onset PD, these enzymes are impaired resulting in the sickness. These proteins are crucial as they remove damaged mitochondria from cells to keep us healthy. The mitochondria is a compartment present in cells, responsible for providing energy. When mitochondria are damaged, Parkin is recruited and clears damage. Parkin is recruited through PINK1, which acts as a damage sensor by accumulating on damaged mitochondria. PINK1 acts like a fire alarm for damage in our body, telling the firemen, Parkin, they are needed. When there is no damage, PINK1 is degraded and removed. For PINK1 to not be degraded, it must bind to a part of the mitochondria called the TOM complex (translocase of the outer membrane complex). This complex is made up of several subunits, but it is unknown how PINK1 interacts with these TOM subunits when mitochondria is damaged. Our objective is to better understand the role of the TOM-complex in the stabilization of PINK1 when there is damage. We will use biochemical approaches that interfere with key connections between PINK1 and TOM subunits. The PINK1-TOM complex is a crucial initiator of a damage repair pathway implicated in PD. This complex could be a potential therapeutic target, reducing suffering of those with PD and the economic burden associated with long-term care of the disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Romanelli, Sabrina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~